Wait, so you are saying they knew the trial was not going to show efficacy for the primary endpoint of PFS? Because that's what it sounds like you are saying. And what about the secondary endpoint of OS, because it sure seems like they knew something about that one, too. That would make any subsequent changes to the trial "post-hoc", which we all know is a big no-no in the eyes of the regulators.

The great thing is that it only took them seven frigging years to come up with a new post-hoc SAP. LOL. This has to be a joke. They are never going to submit this crap trial to the regulators, Gary. The whole thing is a scam, and since 2015 all they've wanted to do is drag this out as long as they can so they can keep paying themselves and so the CEO could set up her own private CDMO, just like she's already done once before. Fool me once . . .